The Urologic Oncology Program provides highly specialized care for patients with tumors of the genitourinary (GU) tract. Our physicians have specialized clinical and research interest in tumors of the prostate, testis, kidney, and bladder. Our group of urologic oncologists, medical oncologists, radiation oncologists, advanced practice nurses, nurse navigators, and clinicians combine their expertise and experience to create the best care plan for their patients.
Rutgers Cancer Institute of New Jersey is a leader in laparoscopic renal procedures and has extensive experience with robotic prostatectomy. The major advantages of robotic prostatectomy include shorter hospital stays, lower blood loss, and faster recovery. Given that robotic surgery is a relatively new technology, surgeon experience is critical for good outcome. Rutgers Cancer Institute has developed a center of excellence for robotic surgery. Our urologic oncologists have performed more than 1,500 robotic prostatectomies over the last five years. Dr. Isaac Kim, Chief of Urologic Oncology, has also developed a new surgical technique for nerve sparing (Athermal Intrafascial Robotic Prostatectomy or AIR prostatectomy) using the robot that leads to faster recovery of sexual function as well as bladder control.
The Urologic Oncology Program offers a wide breadth of clinical trials for patients with tumors of the genitourinary tract. In addition, the Prostate Cancer Program provides a hub for basic and clinical research in prostate cancer as well as a forum for prostate cancer outreach activities.
Useful Links From The Resource and Learning Center: